1

Pharmacokinetics of high-dose cyclophosphamide and its metabolites in paediatric patients

*Pediatric Blood & Cancer* 2011; 57(5):705-897

Abstract 3442: TP53 mutations in favorable risk WNT subtype medulloblastomas

*Cancer Research* 2011; 71(8 Suppl):3442

Investigation of maternal effects, maternal-foetal interactions and parent-of-origin effects (imprinting), using mothers and their offspring

*Genetic Epidemiology* 2009; 33(8):752-835

Changes in baroreflex sensitivity with home orthostatic training in vasovagal syncope - A randomized, placebo controlled pilot study

*Hypertension* 2008; 52(4):747-775

Mismatch repair defects in childhood acutelymphoblastic leukaemia at diagnosis and relapse

*British Journal of Haematology* 2008; 141(S1):1-121

Pharmacogenetic influences on outcome from AC chemotherapy in the treatment of breast cancer

*Breast Cancer Research and Treatment* 2007; 106(S1):1-350

Pharmacogenetics and metabolism of cyclophosphamidein paediatric cancer patients

*Pediatric Blood & Cancer* 2007; 49(4):398-605